Overview

A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and possible efficacy of the use of pentamidine in the treatment of pancreatic cancer metastasis in subjects receiving standard therapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oncozyme Pharma Inc.
Treatments:
Pentamidine